HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shun Watanabe Selected Research

trisialoganglioside GT1

5/2012Involvement of ganglioside GT1b in glutamate release from neuroblastoma cells.
2/2011Intraplantar injection of gangliosides produces nociceptive behavior and hyperalgesia via a glutamate signaling mechanism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shun Watanabe Research Topics

Disease

6Pain (Aches)
01/2023 - 01/2017
6Type 2 Diabetes Mellitus (MODY)
12/2021 - 09/2014
4Hyperalgesia
01/2023 - 02/2011
4Inflammation (Inflammations)
12/2021 - 01/2017
3Neuralgia (Stump Neuralgia)
05/2024 - 05/2021
3Hypersensitivity (Allergy)
05/2024 - 05/2021
3Proteinuria
07/2023 - 08/2020
3Hypertension (High Blood Pressure)
01/2016 - 01/2015
2Diabetic Nephropathies (Diabetic Nephropathy)
01/2023 - 12/2021
2Chronic Renal Insufficiency
01/2023 - 12/2021
2Fibrosis (Cirrhosis)
12/2021 - 01/2017
2Neoplasms (Cancer)
12/2021 - 04/2021
2Renal Cell Carcinoma (Grawitz Tumor)
06/2021 - 04/2021
2Obesity
01/2018 - 07/2017
2Mitochondrial Diseases (Mitochondrial Disease)
01/2016 - 01/2015
1Treatment-Resistant Depressive Disorder
01/2024
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
07/2023
1Rheumatoid Arthritis
07/2023
1Nephritis
07/2023
1Hematuria
07/2023
1Acromegaly
01/2023
1Pituitary Neoplasms (Pituitary Adenoma)
01/2023
1Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
01/2023
1Abscess
11/2022
1Communicable Diseases (Infectious Diseases)
11/2022
1Chronic Pain
01/2022
1Dysbiosis
12/2021
1Renal Insufficiency (Renal Failure)
12/2021
1Dehydration (Water Stress)
11/2021
1Acute Kidney Injury (Acute Renal Failure)
11/2021
1Diabetes Mellitus
11/2021
1Syncope (Fainting)
05/2021
1Pathologic Constriction (Stenosis)
05/2021
1Thrombosis (Thrombus)
04/2021

Drug/Important Bio-Agent (IBA)

4Analgesics (Analgesic Drugs)IBA
05/2024 - 01/2020
3Freund's AdjuvantIBA
01/2023 - 01/2017
3GangliosidesIBA
01/2020 - 02/2011
3Phosphotransferases (Kinase)IBA
04/2017 - 01/2016
3Serotonin (5 Hydroxytryptamine)IBA
04/2016 - 09/2014
2tocilizumab (atlizumab)FDA Link
07/2023 - 08/2020
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2023 - 01/2017
2Sulfoglycosphingolipids (Sulfatides)IBA
01/2023 - 01/2020
2DNA (Deoxyribonucleic Acid)IBA
12/2021 - 01/2015
2EnzymesIBA
12/2021 - 01/2017
2indoleIBA
01/2017 - 01/2016
2AntioxidantsIBA
01/2016 - 01/2015
24- (2,4- difluorophenyl)- 2- (1H- indol- 3- yl)- 4- oxobutanoic acidIBA
01/2016 - 01/2015
2Mitochondrial DNA (mtDNA)IBA
01/2016 - 01/2015
2Adenosine Triphosphate (ATP)IBA
01/2016 - 01/2015
2Glutamic Acid (Glutamate)FDA Link
05/2012 - 02/2011
2trisialoganglioside GT1IBA
05/2012 - 02/2011
1ezogabine (retigabine)IBA
05/2024
1Imipramine (Janimine)FDA LinkGeneric
01/2024
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
07/2023
1Adalimumab (Humira)FDA Link
07/2023
1CTLA-4 AntigenIBA
07/2023
1Peroxidase (Myeloperoxidase)IBA
07/2023
1CreatinineIBA
07/2023
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
07/2023
1Abatacept (Orencia)FDA Link
07/2023
1Biomarkers (Surrogate Marker)IBA
01/2023
1bimosiamoseIBA
01/2023
1Growth Differentiation Factor 15IBA
01/2023
1SelectinsIBA
01/2023
1Nitric Oxide Synthase (NO Synthase)IBA
01/2023
1Carrier Proteins (Binding Protein)IBA
01/2023
1Growth Hormone (Somatotropin)IBA
01/2023
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2023
1Leukocidins (Leukocidin)IBA
11/2022
1Anti-Bacterial Agents (Antibiotics)IBA
11/2022
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2022
1CGP55845IBA
01/2022
11- (2- (tris(4- methoxyphenyl)methoxy)ethyl)- 3- piperidinecarboxylic acidIBA
01/2022
1NNC 711 (NO 711)IBA
01/2022
1Aminobutyrates (Aminobutyric Acid)IBA
01/2022
1GABA Plasma Membrane Transport ProteinsIBA
01/2022
1GATIBA
01/2022
1SGL5213IBA
12/2021
1AdenineFDA LinkGeneric
12/2021
1Glucose (Dextrose)FDA LinkGeneric
12/2021
1SodiumIBA
12/2021
1Sulfates (Sulfates, Inorganic)IBA
12/2021
1Tyrosine (L-Tyrosine)FDA Link
12/2021
1Phenol (Carbolic Acid)FDA Link
12/2021
1Sodium-Glucose Transport ProteinsIBA
11/2021
1Sodium-Glucose Transporter 2 InhibitorsIBA
11/2021
1SugarsIBA
11/2021
1Disopyramide (Norpace)FDA LinkGeneric
05/2021
1Cholinergic Antagonists (Anticholinergics)IBA
05/2021
1Arginine (L-Arginine)FDA Link
05/2021
1Pregabalin (Lyrica)FDA Link
05/2021
1Alanine (L-Alanine)FDA Link
05/2021
1mirogabalinIBA
05/2021
1Gabapentin (Neurontin)FDA LinkGeneric
05/2021

Therapy/Procedure

6Therapeutics
07/2023 - 01/2015
3Ligation
05/2024 - 05/2021
2Spinal Injections
01/2023 - 01/2020
2Nephrectomy
06/2021 - 04/2021
1Aftercare (After-Treatment)
11/2021
1Thrombectomy
04/2021